We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.51B
1-Year Est. Return 164.17%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$825M
AUM Growth
-$13.1M
Cap. Flow
-$4.93M
Cap. Flow %
-0.6%
Top 10 Hldgs %
40.43%
Holding
69
New
13
Increased
13
Reduced
19
Closed
21

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.8M
2
UHS icon
Universal Health Services
UHS
+$31.9M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$28.3M
4
AGN
Allergan Inc
AGN
+$26.3M
5
ZBH icon
Zimmer Biomet
ZBH
+$25.7M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$33.8M
2
A icon
Agilent Technologies
A
+$23.9M
3
BMY icon
Bristol-Myers Squibb
BMY
+$21.7M
4
PODD icon
Insulet
PODD
+$21.7M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$19.8M

Sector Composition

Rank Sector Weight
1 Healthcare 77.75%
2 Technology 2%
3 Communication Services 1.82%
4 Industrials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CERS icon
51
Cerus
CERS
$575M
– –
-586,205
Closed -$2.81M
CLDX icon
52
Celldex Therapeutics
CLDX
$2.78B
– –
-57,596
Closed -$15.3M
HALO icon
53
Halozyme
HALO
$9.59B
– –
-64,167
Closed -$815K
JAZZ icon
54
Jazz Pharmaceuticals
JAZZ
$16B
– –
-142,886
Closed -$19.8M
PBYI icon
55
Puma Biotechnology
PBYI
$408M
– –
-172,092
Closed -$17.9M
PODD icon
56
Insulet
PODD
$11B
– –
-457,048
Closed -$21.7M
THC icon
57
Tenet Healthcare
THC
$17.1B
– –
-789,562
Closed -$33.8M
XOMA
58
DELISTED
Xoma
XOMA
– –
-76,127
Closed -$7.93M
ISEE
59
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-19,374
Closed -$692K
VCRA
60
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-173,408
Closed -$2.83M
GWPH
61
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-323,583
Closed -$19.2M
BSTC
62
DELISTED
BioSpecifics Technologies Corp.
BSTC
– –
-271,620
Closed -$7.04M
PTLA
63
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-452,194
Closed -$11.7M
GNCA
64
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-15,656
Closed -$2.28M
ELGX
65
DELISTED
Endologix Inc
ELGX
– –
-79,510
Closed -$10.2M
NXTM
66
DELISTED
NxStage Medical Inc.
NXTM
– –
-1,090,428
Closed -$13.9M
CYNO
67
DELISTED
Cynosure, Inc. Class A
CYNO
– –
-20,000
Closed -$586K
AFFX
68
DELISTED
Affymetrix Inc
AFFX
– –
-13,500
Closed -$96K
AMBI
69
DELISTED
Ambit Biosciences Corp
AMBI
– –
-367,602
Closed -$3.35M
1 2
3

Similar funds

KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Redmile Group's Q2 2014 Portfolio in Review

As of Q2 2014, Redmile Group held 69 positions worth $825M, down 1.6% from $838M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Redmile Group's Q2 2014 filing shows 13 new, 13 increased, 19 reduced and 21 closed positions. Its largest new stake was Medtronic: 589,974 shares worth $37.6M. The largest sale was Tenet Healthcare, an estimated $33.8M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 80% a quarter earlier, followed by Technology and Communication Services.

  • Redmile Group's largest Q2 2014 buy was Medtronic: 589,974 shares worth $37.6M.
  • Redmile Group added most to Allergan Inc in Q2 2014, an estimated $26.3M increase.
  • Redmile Group's biggest Q2 2014 reduction was Agilent Technologies, cutting an estimated $23.9M.
  • Redmile Group fully exited Tenet Healthcare in Q2 2014, selling an estimated $33.8M.
  • Redmile Group's ten largest holdings make up 40% of its $825M portfolio in Q2 2014.
  • Redmile Group opened 13 new positions and closed 21 in Q2 2014.
  • Redmile Group's portfolio value fell 1.6% quarter-over-quarter to $825M.

Based on Redmile Group's 13F filing for Q2 2014, filed 15 Aug 2014.